BioMedNewsBreaks – ROTH MKM and Sustain SoCal to Co-Host Upcoming PCE6 Event

ROTH MKM and Sustain Southern California (“Sustain SoCal”) today announced plans to jointly host the 6th Annual Sustainability Private Capital Event (“PCE6”), which will take place in a virtual format on Wednesday, Dec. 6, 2023, and Thursday, Dec. 7, 2023. This year’s conference will feature Company Quick Pitches and 1-on-1 / small group ZOOM meetings, providing investors the opportunity to meet with early-stage sustainability companies in cutting-edge domains, including solar/storage, hydrogen, e-mobility, smart city, circular economy, water and agtech.

“The outlook within the sustainability sector remains mixed. The recent passing of the IRA, the IIJA, as well as a series of state laws have benefitted private companies within the sustainability sector. VCs have also enjoyed new fund creation and the deployment of significant private capital. While these factors contribute to a positive outlook, the rapid increase of both inflation and cost of capital have significantly deteriorated public company valuations and have extended this chilling effect in the private company space,” said Jesse Pichel, managing director, co-head sustainability investment banking at ROTH MKM. “Despite the short-term market struggles, we take a long-term approach. We believe the carrot and stick regulations promoting sustainable companies will help mitigate inflationary risks, and the world’s demand for sustainability will continue to gain traction. As such, we continue to support the growth of private companies and have curated a robust group of entities within the sustainability industry for this event.”

To view the full press release, visit https://ibn.fm/zOBWz

About ROTH MKM, LLC

ROTH MKM is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform provides capital raising, high impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH MKM is a privately held, employee-owned organization and maintains offices throughout the U.S. For more information on ROTH MKM, visit www.ROTH.com.

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed)and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

BioMedNewsBreaks — NextPlat Corp. (NASDAQ: NXPL, NXPLW) to Announce Q3 2025 Financial Results on Nov. 13 

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…

17 hours ago

BioMedNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present Sapu003 Data at 2025 San Antonio Breast Cancer Symposium

Oncotelic Therapeutics (OTCQB: OTLC) a biopharmaceutical company advancing transformative cancer therapies through its PDAOAI platform…

4 days ago

BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Schedules Third Quarter 2025 Conference Call for Nov. 13 

HeartBeam (NASDAQ: BEAT), a medical technology company transforming cardiac care through personalized insights, will hold…

5 days ago

BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsWire Editorial on Nanomedicine Advances 

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a NetworkNewsWire (“NNW”) editorial titled “Nanomedicine Innovations…

5 days ago

BioMedNewsBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Granted 180-Day Nasdaq Extension to Regain Minimum Bid Price Compliance

NextPlat (NASDAQ: NXPL, NXPLW), a global consumer products and services company providing healthcare and technology…

6 days ago

BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Receives FDA Meeting Feedback Advancing AVERSA(TM) Fentanyl Toward 505(b)(2) NDA Submission 

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, today announced it has received…

7 days ago